What Pinealon is
Pinealon is a short peptide discussed in aging and neuroprotection conversations, often with broad gene-expression or geroprotection claims.
Pinealon is grouped under Longevity + Skin on PeptideFactCheck because it fits the part of peptide culture that wants clean longevity narratives built around very short sequences.
The useful starting point is to separate the molecule itself from the internet story around it. It fits the part of peptide culture that wants clean longevity narratives built around very short sequences.
Why people keep looking it up
It fits the part of peptide culture that wants clean longevity narratives built around very short sequences.
Pinealon is a short peptide discussed in aging and neuroprotection conversations, often with broad gene-expression or geroprotection claims.
Pinealon tends to stay in the conversation because it touches a familiar public theme: short peptide, aging discussion, and gene-expression claims. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
Mostly early or preclinical longevity-story territory.
Direct human evidence is limited and does not match the certainty of online anti-aging claims.
Most of the story is preclinical or mechanistic rather than robust clinical proof.
Why this page carries the current tier: Mostly early or preclinical longevity-story territory.
The current seed trail for Pinealon is pulling from 1 literature source, 1 trials source, and 1 databases source.
Safety, limits, and regulatory context
Very broad anti-aging claims built on limited short-peptide literature should be treated carefully.
Pinealon is not FDA-approved in the current seed set.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Pinealon. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Molecular and identifier data
The current PubChem match for Pinealon is CID 10273502. That gives the page a source-backed chemistry record rather than a placeholder identifier block.
- PubChem CID
- 10273502
- Formula
- C15H26N6O8
- Molecular weight
- 418.40
- InChIKey
- QPRZKNOOOBWXSU-CIUDSAMLSA-N
Matched synonyms include Glu-Asp-Arg, glutamyl-aspartyl-arginine, CHEBI:156374, L-Glutamyl-L-aspartyl-L-arginine, RefChem:143534, pinealon, 175175-23-2, Pinealon acetate salt form.
Open PubChem recordClinical trial snapshot
The current ClinicalTrials.gov intervention query for Pinealon returns 0 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
No linked intervention records were returned by the current ClinicalTrials.gov query terms for this page.
Literature snapshot
The current PubMed query for Pinealon returns 24 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.